Eli Lilly Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant bearish stance has been taken on Eli Lilly (NYSE:LLY) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 43% bullish and 56% bearish. The big players have been eyeing a price window from $250.0 to $620.0 for Eli Lilly during the past quarter. Analysts from Citigroup, Cantor Fitzgerald, Wells Fargo, and Morgan Stanley have given Eli Lilly a Buy or Overweight rating, with price targets ranging from $630 to $675.
November 07, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Unusual options activity indicates a significant bearish stance on Eli Lilly. The sentiment among big-money traders is split, with 56% bearish. Analysts maintain Buy or Overweight ratings, with price targets from $630 to $675.
The unusual options activity, with a significant bearish stance, indicates that there may be a potential downside for Eli Lilly's stock in the short term. This is further supported by the fact that 56% of the big-money traders are bearish. However, analysts' ratings are mostly positive, which could potentially mitigate some of the bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100